glp 1 nine in one GLP‐1 Receptor Agonists for Treating Alcohol Use Disorder: A Critical Review - Woo - 2026 - Alcohol, Clinical and Experimental Research Ozempic and Other GLP-1 Drugs

Alzheimer's disease and the amyloid-beta peptide

doi: 10.1186/1743-7075-2-25

No UK Marketing Authorisation Identified No current UK marketing authorisation for a medicinal product containing Epithalon, Epitalon or AEDG was identified in the official product sources reviewed for this article

Retatrutide: Published Research Summary A bibliographic summary of the primary peer-reviewed literature on retatrutide (LY3437943), tracing the compound from its founding discovery paper through cryo-EM structural biology and its phase 1 and phase 2 clinical trial program

Dietary modification alone is insufficient for treating established deficiency but plays a supportive role in prevention

Access to existing therapies or development of novel ones